Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin

Academic Article

Abstract

  • Lomefloxacin was found to be comparable to ciprofloxacin in its ability to inhibit the in vitro growth of Mycoplasma pneumoniae (MIC range 2-8 mcg/ml), but it was significantly less active than erythromycin. Although 30 different strains from widely differing geographic areas and isolation time periods were examined, no macrolide-resistant strains were observed. © 1989.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Cassell GH; Waites KB; Pate MS; Canupp KC; Duffy LB
  • Start Page

  • 433
  • End Page

  • 435
  • Volume

  • 12
  • Issue

  • 5